Induction of laryngeal cancer cell death by Ent-11-hydroxy-15-oxo-kaur-16- en-19-oic acid

Head and Neck

Volumn 32, Issue 11, 2010, Pages 1506-1518

  Vlantis, Alexander C ^a   Lo, Chun Shan ^a   Chen, George G ^a   Ci Liang, Nian ^b   Lui, Vivian W Y ^a   Wu, Kefeng ^b   Deng, Yi Feng ^b   Gong, Xianling ^b   Lu, Yingnian ^b   Tong, Michael C F ^a   Van Hasselt, C Andrew ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b GUANGDONG MEDICAL UNIVERSITY   (China)

Author keywords

apoptosis; cell death; laryngeal cancer; nuclear factor kappaB; Pteris semipinnata L

Indexed keywords

ANTINEOPLASTIC AGENT; ENT 11 HYDROXY 15 OXO KAUR 16 EN 19 OIC ACID; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOCORTIN 5; POLY(ADENOSINE DIPHOSPHATE RIBOSE); PROCASPASE 3; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL DEATH; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; HUMAN CELL; LARYNX CANCER; PRIORITY JOURNAL; PROTEIN DEGRADATION;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; CASPASE 3; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN D1; CYCLOOXYGENASE 2; DITERPENES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; DRUGS, CHINESE HERBAL; HUMANS; I-KAPPA B KINASE; LARYNGEAL NEOPLASMS; MICROTUBULE-ASSOCIATED PROTEINS; NF-KAPPA B; POLY(ADP-RIBOSE) POLYMERASES; RECEPTOR, EPIDERMAL GROWTH FACTOR; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 78649490182     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21357     Document Type: Article

References (32)

1. Franceschi S, Muñoz N, Bosch XF, Snijders PJ, Walboomers JM,. Human papillomavirus and cancers of the upper aerodigestive tract: a review of epidemiological and experimental evidence. Cancer Epidemiol Biomarkers Prev 1996; 5: 567-575.
2. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin 2006; 56: 106-130.
3. Lu Y, Li CS, Dong Q,. Chinese herb related molecules of cancer-cell-apoptosis: a minireview of progress between Kanglaite injection and related genes. J Exp Clin Cancer Res 2008; 27: 31.
4. Chen GG, Liang NC, Lee JF, et al. Over-expression of Bcl-2 against Pteris semipinnata L-induced apoptosis of human colon cancer cells via a NF-kappa B-related pathway. Apoptosis 2004; 9: 619-627.
5. Liu Z, Ng EK, Liang NC, Deng YF, Leung BC, Chen GG,. Cell death induced by Pteris semipinnata L. is associated with p53 and oxidant stress in gastric cancer cells. FEBS Lett 2005; 579: 1477-1487.
6. Liu ZM, Chen GG, Vlantis AC, Liang NC, Deng YF, van Hasselt CA,. Cell death induced by ent-11alpha-hydroxy-15-oxo-kaur-16-en-19-oic-acid in anaplastic thyroid carcinoma cells is via a mitochondrial-mediated pathway. Apoptosis 2005; 10: 1345-1356.
7. Li L, Aggarwal BB, Shishodia S, Abbruzzese J, Kurzrock R,. Nuclear factor-kappaB and IkappaB kinase are constitutively active in human pancreatic cells, and their down-regulation by curcumin (diferuloylmethane) is associated with the suppression of proliferation and the induction of apoptosis. Cancer 2004; 101: 2351-2362.
8. Nakshatri H, Bhat-Nakshatri P, Martin DA, Goulet RJ Jr, Sledge GW Jr,. Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth. Mol Cell Biol 1997; 17: 3629-3639.
9. Shukla S, MacLennan GT, Fu P, et al. Nuclear factor-kappaB/p65 (Rel A) is constitutively activated in human prostate adenocarcinoma and correlates with disease progression. Neoplasia 2004; 6: 390-400.
10. Allen CT, Ricker JL, Chen Z, Van Waes C,. Role of activated nuclear factor-kappaB in the pathogenesis and therapy of squamous cell carcinoma of the head and neck. Head Neck 2007; 29: 959-971.
11. Levidou G, Korkolopoulou P, Nikiteas N, et al. Expression of nuclear factor kappaB in human gastric carcinoma: relationship with I kappaB and prognostic significance. Virchows Arch 2007; 450: 519-527.
12. Du J, Chen GG, Vlantis AC, Xu H, Tsang RK, van Hasselt CA,. The nuclear localization of NFkappaB and p53 is positively correlated with HPV16 E7 level in laryngeal squamous cell carcinoma. J Histochem Cytochem 2003; 51: 533-539.
13. Guo Y, Liu J, Xu Z, Sun K, Fu W,. HLA-B gene participates in the NF-kappaB signal pathway partly by regulating S100A8 in the laryngeal carcinoma cell line Hep2. Oncol Reports 2008; 19: 1453-1459.
14. Kourelis K, Sotiropoulou-Bonikou G, Vandoros G, Repanti M, Varakis I, Goumas P,. Coordinated upregulation of COX-2 and NF-kappaB is a steady feature of laryngeal carcinogenesis. ORL J Otorhinolaryngol Relat Spec 2007; 69: 181-189.
15. Aggarwal BB, Takada Y,. Pro-apototic and anti-apoptotic effects of tumor necrosis factor in tumor cells. Role of nuclear transcription factor NF-kappaB. Cancer Treat Res 2005; 126: 103-127.
16. Mori N, Yamada Y, Ikeda S, et al. Bay 11-7082 inhibits transcription factor NF-kappaB and induces apoptosis of HTLV-I-infected T-cell lines and primary adult T-cell leukemia cells. Blood 2002; 100: 1828-1834.
17. Polsky D, Cordon-Cardo C,. Oncogenes in melanoma. Oncogene 2003; 22: 3087-3091.
18. Chun KS, Surh YJ,. Signal transduction pathways regulating cyclooxygenase-2 expression: potential molecular targets for chemoprevention. Biochem Pharmacol 2004; 68: 1089-1100.
19. Nishi H, Neta G, Nishi KH, et al. Analysis of the epidermal growth factor receptor promoter: the effect of nuclear factor-kappaB. Int J Mol Med 2003; 11: 49-55.
20. Zucchini C, Rocchi A, Manara MC, et al. Apoptotic genes as potential markers of metastatic phenotype in human osteosarcoma cell lines. In J Oncol 2008; 32: 17-31.
21. van Delft MF, Huang DC,. How the Bcl-2 family of proteins interact to regulate apoptosis. Cell Res 2006; 16: 203-213.
22. Karin M, Lin A,. NF-kappaB at the crossroads of life and death. Nat Immunol 2002; 3: 221-227.
23. Vancurova I, Wu R, Miskolci V, Sun S,. Increased p50/p50 NF-kappaB activation in human papillomavirus type 6- or type 11-induced laryngeal papilloma tissue. J Virol 2002; 76: 1533-1536.
24. Karin M, Yamamoto Y, Wang QM,. The IKK NF-kappa B system: a treasure trove for drug development. Nat Rev Drug Discov 2004; 3: 17-26.
25. Wahl C, Liptay S, Adler G, Schmid RM,. Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B. J Clin Invest 1998; 101: 1163-1174.
26. Yan F, Polk DB,. Aminosalicylic acid inhibits IkappaB kinase alpha phosphorylation of IkappaBalpha in mouse intestinal epithelial cells. J Biol Chem 1999; 274: 36631-36636.
27. Karin M,. Nuclear factor-kappaB in cancer development and progression. Nature 2006; 441: 431-436.
28. Marioni G, Bertolin A, Giacomelli L, et al. Expression of the apoptosis inhibitor protein Survivin in primary laryngeal carcinoma and cervical lymph node metastasis. Anticancer Res 2006; 26: 3813-3817.
29. Van Waes C, Chang AA, Lebowitz PF, et al. Inhibition of nuclear factor-kappaB and target genes during combined therapy with proteasome inhibitor bortezomib and reirradiation in patients with recurrent head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2005; 63: 1400-1412.
30. Wei Q, Sheng L, Shui Y, Hu Q, Nordgren H, Carlsson J,. EGFR, HER2, and HER3 expression in laryngeal primary tumors and corresponding metastases. Ann Surg Oncol 2008; 15: 1193-1201.
31. Sarkar FH, Li Y,. NF-kappaB: a potential target for cancer chemoprevention and therapy. Front Biosci 2008; 13: 2950-2959.
32. Landsford CD, Grenman R, Bier H, et al. In:, Masters JRW, Pulsson B, editors. Human cell culture, vol II: Head and neck cancers. Norwell, MA: Kluwer Academic; 1999. pp 185-255.